Duyuru • May 10
HOYA Corporation to Report Q3, 2027 Results on Feb 01, 2027 HOYA Corporation announced that they will report Q3, 2027 results on Feb 01, 2027 Duyuru • Apr 30
HOYA Corporation, Annual General Meeting, Jun 26, 2026 HOYA Corporation, Annual General Meeting, Jun 26, 2026. Duyuru • Apr 21
HOYA Corporation to Report Fiscal Year 2026 Results on Apr 30, 2026 HOYA Corporation announced that they will report fiscal year 2026 results on Apr 30, 2026 Duyuru • Jan 30
HOYA Corporation (TSE:7741) announces an Equity Buyback for 500,000 shares, representing 1.48% for ¥100,000 million. HOYA Corporation (TSE:7741) announces a share repurchase program. Under the program, the company will repurchase up to 500,000 shares, representing 1.48% of its total shares outstanding excluding treasury shares, for a total of ¥100,000 million. The purpose of repurchase program is to strengthen shareholder returns, improve capital efficiency, and implement flexible capital policies. Purchased stocks are planned to be cancelled with the aim of shareholders’ benefit. The repurchase program is valid till July 17, 2026. As of August 1, 2025, the company had 338,078,276 shares outstanding excluding treasury shares and had 336,044 shares in treasury. Duyuru • Oct 31
HOYA Corporation Announces Interim Dividend for the Fiscal Year Ending March 31, 2026, Payable on November 28, 2025 HOYA Corporation announced that the Board of Directors, at its meeting held on October 31, 2025, resolved to pay the interim dividend of JPY 125.00 per share to the shareholders registered as of September 30, 2025, against previous dividend of JPY 45.00 per share paid a year ago. Date of payment is November 28, 2025. Duyuru • Sep 24
PENTAX Medical and Advanced Sterilization Products Launch the Sterilizable Dec™? Duodenoscope PENTAX Medical, in partnership with Advanced Sterilization Products (ASP), announces the U.S. launch of the Sterilizable DEC™? Duodenoscope, a revolutionary reusable duodenoscope that delivers the predictable handling physicians expect, now with the option for complete sterilization in just 68 minutes using ASP's STERRAD™? System. Unlike single-use alternatives, this next-generation endoscope is engineered for sterility, stability, and control, helping physicians navigate procedures with confidence--while supporting infection prevention and improved operational efficiency. Developed in response to long-standing concerns around cross-contamination, the system enables facilities to enhance infection control with rapid sterilization capabilities and a safer, more sustainable reprocessing experience. Built-in sterilization compatibility allows facilities to tailor workflows without compromising safety--supporting staff, patients, and environmental goals. The product became available in the U.S. beginning July 1, 2025. Duyuru • Aug 21
HOYA Corporation (TSE:7741) announces an Equity Buyback for 6,200,000 shares, representing 1.81% for ¥100,000 million. HOYA Corporation (TSE:7741) announces a share repurchase program. Under the program, the company will repurchase up to 6,200,000 shares, representing 1.81% of its total shares outstanding excluding treasury shares, for a total of ¥100,000 million. The purpose of repurchase program is to strengthen shareholder returns, improve capital efficiency, and implement flexible capital policies. The repurchase program is valid till January 21, 2026. As of August 1, 2025, the company had 342,762,990 shares outstanding excluding treasury shares and had 359,630 shares in treasury. Duyuru • Aug 20
Hoya Vision Care Raises the Bar with Sun Lenses Designed for Optimum Performance and Lasting Durability HOYA®? Vision Care has raised the bar in sun lens solutions for eye care professionals. This summer alone, HOYA launched three innovative sun lens products: HOYA Polarized™?, HOYA Polarized HEV™?, and HOYA Polarized Lenses with Lumacore™? Mirrors. HOYA's polarized lens portfolio showcases the company's advanced technologies, including embedded mirror coatings, solar blue light filtration, and fashion-forward color options, catering to a wide range of patient lifestyles and visual needs. HOYA Polarized L lenses with Lumacore™?Mirrors are designed for long-lasting performance, using embedded mirror technology that resists scratching, peeling, and fading beyond traditional coatings. By integrating the mirror color directly into the lens, Lumacore ensures superior durability, enhanced clarity, and reduced glare for a more comfortable visual experience. Designed to withstand everyday wear, these lenses are easy to maintain and keep their bold, vibrant look over time. HOYA Polarized™ lenses combine style and performance, offering three fashion-forward colors and gradient options to suit any look. Available in a wide range of designs, including LifeStyle 3 Sun, and compatible with new HOYA mirror coatings, these lenses help reduce glare and unpleasant reflections in excessive sunlight, increasing visual comfort. With features like enhanced contrast for night driving and added UV protection, HOYA Polarized lenses meet everyday lifestyle needs. HOYA Polarized HEV™ lenses provide contrast-rich vision and offer 97% solar blue light protection. They are darker than standard polarized options, improving comfort in bright conditions while enhancing contrast and visual clarity. Designed for durability, they are available in impact-resistant polycarbonate in gray, brown, and green. Now through September 30, 2025, new and current Visionary Alliance members can earn additional rewards on HOYA polarized lenses. The promotion includes HOYA's new HOYA Polarized Lenses with Lumacore™ Mirrors, HOYA Polarized™, and HOYA Polarized HEV™ lens orders. ECPs who wish to participate but aren't currently members can enroll in the program without commitments or contracts. Duyuru • Jun 13
HOYA Corporation Receives Written Verdict from the Tokyo District Court HOYA Corporation announced that it received a written verdict from the Tokyo District Court (the Court) regarding the lawsuit filed to cancel the reassessment based on the transfer pricing taxation. The Company had previously received a reassessment notice from the Tokyo Regional Taxation Bureau in June 2013, based on transfer pricing taxation regarding transactions with Company's overseas subsidiaries from the fiscal year ended March 31, 2007 through the fiscal year ending March 31, 2011. Subsequently, received a written decision from the National Tax Tribunal to rescind a part of the disposition in request for review. However, there is a discrepancy with claim regarding the part of the disposition that was not rescinded, so the filed a lawsuit with the Court in September 2018 to request the revocation of this reassessment and have been submitting with the proceedings. The company has recently received a ruling from the Court that cancels about JPY 1.3 billion in corporate tax, local taxes, and others, out of the amount of the reassessment. The Company disagrees with the other findings of the Court's verdict that maintains portions of the reassessment and expects to appeal to the findings in the Court to seek cancellation of all the reassessments in accordance with the relevant law. This result is not expected to materially impact HOYA's financial performance on a consolidated basis. Duyuru • May 01
HOYA Corporation, Annual General Meeting, Jun 26, 2025 HOYA Corporation, Annual General Meeting, Jun 26, 2025. Duyuru • Feb 28
HOYA Corporation to Report Fiscal Year 2025 Results on May 01, 2025 HOYA Corporation announced that they will report fiscal year 2025 results on May 01, 2025 Duyuru • Feb 03
HOYA Corporation (TSE:7741) announces an Equity Buyback for 3,000,000 shares, representing 0.87% for ¥50,000 million. HOYA Corporation (TSE:7741) announces a share repurchase program. Under the program, the company will repurchase up to 3,000,000 shares, representing 0.87% of its total shares outstanding excluding treasury shares, for a total of ¥50,000 million. The purpose of repurchase program is to strengthen shareholder returns, improve capital efficiency, and implement flexible capital policies. The repurchase program is valid till April 21, 2025. As of February 3, 2025, the company had 345,481,111 shares outstanding excluding treasury shares and had 2,845,309 shares in treasury. Duyuru • Nov 01
HOYA Corporation (TSE:7741) announces an Equity Buyback for 3,000,000 shares, representing 0.86% for ¥50,000 million. HOYA Corporation (TSE:7741) announces a share repurchase program. Under the program, the company will repurchase up to 3,000,000 shares, representing 0.86% of its total shares outstanding excluding treasury shares, for a total of ¥50,000 million. The purpose of repurchase program is to strengthen shareholder returns, improve capital efficiency, and implement flexible capital policies. The repurchase program is valid till January 22, 2025. As of September 30, 2024, the company had 347,922,719 shares outstanding excluding treasury shares and had 3,036,001 shares in treasury. Duyuru • Oct 31
HOYA Corporation Announces Interim Dividend for the Fiscal Year Ending March 31, 2025, Payable on November 29, 2024 HOYA Corporation announced that the Board of Directors, at its meeting held on October 31, 2024, resolved to pay the interim dividend of JPY 45.00 per share to the shareholders registered as of September 30, 2024, against previous dividend of JPY 45.00 per share paid a year ago. Date of payment is November 29, 2024. Duyuru • Aug 06
Advanced Sterilization Products Announces FDA Clearance for Revolutionary Sterilization Cycle for Duodenoscopes in Partnership with PENTAX Medical, a Division of HOYA Advanced Sterilization Products (ASP), a division of Fortive, in collaboration with PENTAX Medical, a division of HOYA, announced the FDA clearance of the new ULTRA GI™ Cycle in its product, the STERRAD™ 100NX Sterilizer with ALLClear™ Technology. The ULTRA GI™ Cycle is specifically and uniquely designed to reprocess duodenoscopes using hydrogen peroxide gas plasma sterilization. The FDA clearance marks a significant milestone in advancing patient safety and addressing the challenges associated with current reprocessing methods for duodenoscopes. This sterilization cycle is set to revolutionize sterilization practices in healthcare facilities, ensuring a new standard of safety and efficacy. Duodenoscopes have been under scrutiny due to their relatively high contamination rates, prompting the urgent need for a robust sterilization solution. The collaborative effort between ASP and PENTAX Medical has resulted in an innovative method that not only meets but exceeds industry standards, providing healthcare professionals with a powerful tool to enhance patient safety. Duyuru • May 25
Hoya Corporation Announces Dividend for the Year Ending March 31, 2024, Payable on June 10, 2024 HOYA Corporation announced dividend of JPY 65 per share compared to JPY 65 per share a year ago. Date of payment June 10, 2024. Duyuru • May 17
HOYA Corporation, Annual General Meeting, Jun 27, 2024 HOYA Corporation, Annual General Meeting, Jun 27, 2024. Duyuru • May 16
HOYA Corporation (TSE:7741) announces an Equity Buyback for 3,000,000 shares, representing 0.86% for ¥50,000 million. HOYA Corporation (TSE:7741) announces a share repurchase program. Under the program, the company will repurchase up to 3,000,000 shares, representing 0.86% of its total shares outstanding excluding treasury shares, for a total of ¥50,000 million. The purpose of repurchase program is to strengthen shareholder returns, improve capital efficiency, and implement flexible capital policies. The repurchase program is valid till August 15, 2024. As of March 31, 2024, the company had 350,521,475 shares outstanding excluding treasury shares and had 437,245 shares in treasury. Duyuru • Mar 02
HOYA Corporation to Report Fiscal Year 2024 Results on May 01, 2024 HOYA Corporation announced that they will report fiscal year 2024 results on May 01, 2024 Duyuru • Nov 02
Hoya Corporation Announces Interim Dividend for the Six Months Ended September 30, 2023 HOYA Corporation announced interim dividend of JPY 45.00 per share for the six months ended September 30, 2023 compared to JPY 45.00 per share paid a year ago. Duyuru • Aug 27
HOYA Corporation to Report Q3, 2024 Results on Feb 01, 2024 HOYA Corporation announced that they will report Q3, 2024 results on Feb 01, 2024 Duyuru • Aug 01
HOYA Corporation (TSE:7741) announces an Equity Buyback for 3,600,000 shares, representing 1.02% for ¥50,000 million. HOYA Corporation (TSE:7741) announces a share repurchase program. Under the program, the company will repurchase up to 3,600,000 shares, representing 1.02% of its total outstanding share capital, excluding treasury stock, for a total purchase price of ¥50,000 million. The purpose of the program is to enhance shareholder returns, improve capital efficiency, and implement flexible capital policies. The program will continue through October 20, 2023. As of July 25, 2023, the company had 353,625,331 outstanding shares (excluding treasury stock) and 463,189 treasury shares. Duyuru • Jul 29
HOYA Corporation to Report Q2, 2024 Results on Oct 31, 2023 HOYA Corporation announced that they will report Q2, 2024 results on Oct 31, 2023 Duyuru • Jun 28
HOYA Corporation to Report Q1, 2024 Results on Jul 31, 2023 HOYA Corporation announced that they will report Q1, 2024 results on Jul 31, 2023 Duyuru • Feb 01
HOYA Corporation (TSE:7741) announces an Equity Buyback for 3,600,000 shares, representing 1.01% for ¥40,000 million. HOYA Corporation (TSE:7741) announces a share repurchase program. Under the program, the company will repurchase up to 3,600,000 shares, representing 1.01% of its total outstanding share capital, excluding treasury stock, for a total purchase price of ¥40,000 million. The purpose of the program is to enhance shareholder returns, improve capital efficiency, and implement flexible capital policies. The program will continue through April 20, 2023. As of January 25, 2023, the company had 356,434,731 outstanding shares (excluding treasury stock) and 525,789 treasury shares. Duyuru • Dec 28
HOYA Corporation to Report Q3, 2023 Results on Jan 31, 2023 HOYA Corporation announced that they will report Q3, 2023 results on Jan 31, 2023